A Case of Cycloserine-Induced Lichenoid Drug Eruption Supported by the Lymphocyte Transformation Test

Allergy Asthma Immunol Res. 2017 May;9(3):281-284. doi: 10.4168/aair.2017.9.3.281.

Abstract

Lichenoid drug eruption (LDE) is a rare form of delayed-type drug eruption. Among anti-tuberculosis (Tb) agents, cycloserine (CS) has been reported as a rare cause of LDE. Positive results on the lymphocyte transformation test (LTT) have not been reported in patients with LDE. In the present case, we performed LTT and a patch test, and successfully proved CS as the offending drug in this patient, who had been treated with multiple anti-Tb drugs. These observations suggest that CS should be considered a possible cause of LDE and that LTT can be an option for the diagnosis of LDE.

Keywords: Cycloserine; drug eruptions; drug hypersensitivity; lichenoid eruptions; lymphocyte activation.

Publication types

  • Case Reports
  • Letter